LV10108B - Inhibitors of cells proliferation, pharmaceutical composition, process of producing of compounds, methods of inhibition of cellular proliferation - Google Patents
Inhibitors of cells proliferation, pharmaceutical composition, process of producing of compounds, methods of inhibition of cellular proliferation Download PDFInfo
- Publication number
- LV10108B LV10108B LVP-92-589A LV920589A LV10108B LV 10108 B LV10108 B LV 10108B LV 920589 A LV920589 A LV 920589A LV 10108 B LV10108 B LV 10108B
- Authority
- LV
- Latvia
- Prior art keywords
- formula
- asp
- cys
- compounds
- glu
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4722—G-proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888821785A GB8821785D0 (en) | 1988-09-16 | 1988-09-16 | Peptide compounds |
PCT/EP1989/001071 WO1990002753A1 (en) | 1988-09-16 | 1989-09-13 | Peptide compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
LV10108A LV10108A (lv) | 1994-05-10 |
LV10108B true LV10108B (en) | 1994-10-20 |
Family
ID=10643722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-92-589A LV10108B (en) | 1988-09-16 | 1992-12-30 | Inhibitors of cells proliferation, pharmaceutical composition, process of producing of compounds, methods of inhibition of cellular proliferation |
Country Status (22)
Country | Link |
---|---|
US (1) | US5484770A (zh) |
EP (2) | EP0434718A1 (zh) |
JP (1) | JPH04500666A (zh) |
KR (1) | KR900701828A (zh) |
CN (1) | CN1041159A (zh) |
AT (1) | ATE110742T1 (zh) |
AU (1) | AU641366B2 (zh) |
CA (1) | CA1339947C (zh) |
DE (1) | DE68917837T2 (zh) |
DK (1) | DK39591A (zh) |
ES (1) | ES2058479T3 (zh) |
GB (1) | GB8821785D0 (zh) |
GE (1) | GEP19971041B (zh) |
HU (2) | HU208027B (zh) |
IE (1) | IE64181B1 (zh) |
LT (1) | LT3714B (zh) |
LV (1) | LV10108B (zh) |
MY (1) | MY104909A (zh) |
NZ (1) | NZ230654A (zh) |
RU (1) | RU2079509C1 (zh) |
WO (1) | WO1990002753A1 (zh) |
ZA (1) | ZA896980B (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5620957A (en) * | 1989-07-14 | 1997-04-15 | Smithkline Beecham Corporation | Hemoregulatory peptides |
HU206372B (en) * | 1990-09-03 | 1992-10-28 | Richter Gedeon Vegyeszet | Process for producing new oligopeptides which selectively inhibit proliferation of haemopoietic cells and pharmaceutical compositions comprising same |
HU206374B (en) * | 1990-09-03 | 1992-10-28 | Richter Gedeon Vegyeszet | Process for producing pentapeptide and its salts specifically inhibiting proliferation of epidermic cells, as well as pharmaceutical compositions comprising same as active ingredient |
TW222280B (zh) * | 1991-11-26 | 1994-04-11 | Smithkline Beecham Corp | |
IL104323A0 (en) * | 1992-01-10 | 1993-05-13 | Smithkline Beecham Corp | Hemoregulatory peptides |
GB9211668D0 (en) | 1992-06-02 | 1992-07-15 | Nycomed Bioreg As | Peptide compounds |
GB9211677D0 (en) | 1992-06-02 | 1992-07-15 | Nycomed Bioreg As | Peptide compounds |
GB9211674D0 (en) | 1992-06-02 | 1992-07-15 | Nycomed Bioreg As | Peptide compounds |
GR1001502B (el) * | 1992-11-26 | 1994-02-28 | Smithkline Beecham Corp | Αιμορυ?μιστικά πεπτίδια. |
CN1034735C (zh) * | 1993-01-02 | 1997-04-30 | 史密丝克莱恩比彻姆公司 | 血调节肽 |
US5504191A (en) * | 1994-08-01 | 1996-04-02 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory pentapeptide methyl esters |
US5521284A (en) * | 1994-08-01 | 1996-05-28 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Human cancer inhibitory pentapeptide amides and esters |
CN1403474A (zh) * | 2001-09-05 | 2003-03-19 | 中国人民解放军军事医学科学院生物工程研究所 | 一种短肽及以其为活性成份的药物 |
CA2491946C (en) | 2002-07-23 | 2013-05-28 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R | Ghrelin analogs |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA838780B (en) * | 1982-11-26 | 1985-01-30 | Nyegaard & Co As | Peptide compounds |
NO860752L (no) * | 1985-06-26 | 1986-12-29 | Bio Tech As | Pentapeptider med cellevekstregulerende virkning og fremgangsmaate for fremstilling derav. |
US4748154A (en) * | 1985-12-24 | 1988-05-31 | Takeda Chemical Industries, Ltd. | Peptide derivatives, their production and use |
GB8626539D0 (en) * | 1986-11-06 | 1986-12-10 | Nycomed As | Peptide compounds |
-
1988
- 1988-09-16 GB GB888821785A patent/GB8821785D0/en active Pending
-
1989
- 1989-09-13 AT AT89202310T patent/ATE110742T1/de not_active IP Right Cessation
- 1989-09-13 US US07/671,757 patent/US5484770A/en not_active Expired - Fee Related
- 1989-09-13 HU HU895788A patent/HU208027B/hu not_active IP Right Cessation
- 1989-09-13 WO PCT/EP1989/001071 patent/WO1990002753A1/en not_active Application Discontinuation
- 1989-09-13 ZA ZA896980A patent/ZA896980B/xx unknown
- 1989-09-13 RU SU894895033A patent/RU2079509C1/ru active
- 1989-09-13 AU AU42183/89A patent/AU641366B2/en not_active Ceased
- 1989-09-13 JP JP1509617A patent/JPH04500666A/ja active Pending
- 1989-09-13 KR KR1019900700453A patent/KR900701828A/ko active IP Right Grant
- 1989-09-13 ES ES89202310T patent/ES2058479T3/es not_active Expired - Lifetime
- 1989-09-13 EP EP89910097A patent/EP0434718A1/en active Pending
- 1989-09-13 HU HU895788A patent/HU895788D0/hu unknown
- 1989-09-13 DE DE68917837T patent/DE68917837T2/de not_active Expired - Fee Related
- 1989-09-13 EP EP89202310A patent/EP0359338B1/en not_active Expired - Lifetime
- 1989-09-14 NZ NZ230654A patent/NZ230654A/xx unknown
- 1989-09-15 MY MYPI89001265A patent/MY104909A/en unknown
- 1989-09-15 CA CA000611592A patent/CA1339947C/en not_active Expired - Fee Related
- 1989-09-15 IE IE295489A patent/IE64181B1/en not_active IP Right Cessation
- 1989-09-16 CN CN89107159A patent/CN1041159A/zh active Pending
-
1991
- 1991-03-06 DK DK039591A patent/DK39591A/da not_active Application Discontinuation
-
1992
- 1992-12-30 LV LVP-92-589A patent/LV10108B/lv unknown
-
1993
- 1993-06-03 LT LTIP610A patent/LT3714B/lt not_active IP Right Cessation
- 1993-07-16 GE GEAP19931053A patent/GEP19971041B/en unknown
Also Published As
Publication number | Publication date |
---|---|
IE64181B1 (en) | 1995-07-12 |
IE892954L (en) | 1990-03-16 |
AU4218389A (en) | 1990-04-02 |
MY104909A (en) | 1994-06-30 |
DK39591D0 (da) | 1991-03-06 |
LTIP610A (en) | 1994-12-27 |
JPH04500666A (ja) | 1992-02-06 |
KR900701828A (ko) | 1990-12-04 |
HU208027B (en) | 1993-07-28 |
EP0359338B1 (en) | 1994-08-31 |
LV10108A (lv) | 1994-05-10 |
DK39591A (da) | 1991-03-06 |
EP0434718A1 (en) | 1991-07-03 |
HUT58765A (en) | 1992-03-30 |
DE68917837T2 (de) | 1994-12-22 |
RU2079509C1 (ru) | 1997-05-20 |
ATE110742T1 (de) | 1994-09-15 |
CA1339947C (en) | 1998-07-07 |
HU895788D0 (en) | 1991-08-28 |
LT3714B (en) | 1996-02-26 |
US5484770A (en) | 1996-01-16 |
EP0359338A1 (en) | 1990-03-21 |
GB8821785D0 (en) | 1988-10-19 |
ES2058479T3 (es) | 1994-11-01 |
ZA896980B (en) | 1990-06-27 |
CN1041159A (zh) | 1990-04-11 |
NZ230654A (en) | 1991-10-25 |
WO1990002753A1 (en) | 1990-03-22 |
DE68917837D1 (de) | 1994-10-06 |
GEP19971041B (en) | 1997-11-26 |
AU641366B2 (en) | 1993-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5604203A (en) | Analogs of peptide YY and uses thereof | |
EP0309297B1 (en) | Therapeutic peptides | |
JP2744910B2 (ja) | ペプチド誘導体類 | |
KR101319740B1 (ko) | 시클릭 펩티드 cxcr4 길항제 | |
FI104252B (fi) | Menetelmä terapeuttisesti käyttökelpoisten peptidien kemialliseksi syntetisoimiseksi kiinteässä faasissa | |
US4499081A (en) | Peptide compounds | |
WO2004020462A1 (ja) | Cxcr4拮抗薬およびその用途 | |
RU2115659C1 (ru) | Производные нонапептидов или их солей с фармацевтически приемлемыми кислотами, способ их получения и фармацевтическая композиция | |
PT2213680E (pt) | Péptidos que possuem uma atividade farmacológica para o tratamento de distúrbios associados à migração de células alteradas, tais como o cancro | |
LV10108B (en) | Inhibitors of cells proliferation, pharmaceutical composition, process of producing of compounds, methods of inhibition of cellular proliferation | |
DK2473518T3 (en) | Stabilized melanocortin ligands | |
NO313418B1 (no) | Bombesinantagonistpeptider, farmasöytisk sammensetning inneholdende disse, samt anvendelse | |
NO177713B (no) | Analogifremgangsmåte ved fremstilling av hemoreguleringspeptider | |
EP0333071A2 (en) | Polypeptides, methods for their preparation, pharmaceutical compositions comprising them and use | |
US4481194A (en) | Des-proline-des-glycine vasopressin antagonists | |
CA2405704C (en) | Bombesin analogs for treatment of cancer | |
CA2405724C (en) | Substance p analogs for the treatment of cancer | |
JPS62209096A (ja) | バソプレシン化合物 | |
WO2014075137A1 (en) | Peptides incorporating amino-substituted lactams for treatment of retinopathy | |
JPH03141298A (ja) | 活性ペプチド | |
GB1568195A (en) | Synthetc peptides | |
CA2008454A1 (en) | Linear analog of biologically active mammalian grp or amphibian bombesin |